Web Analytics
SILO (NASDAQ) Stock Analysis | SILO PHARMA INC – Deepscope
MARKET

Select Market Data Region

SILO — SILO PHARMA INC (Healthcare >> Biotechnology)

SILO FAQ

What is SILO's ROE?

SILO PHARMA INC reports a Return on Equity (ROE) of -85.24%.

What is SILO's dividend yield?

SILO PHARMA INC offers a dividend yield of 0.00%.

What is SILO's Deepscope Quality Score?

Deepscope rates SILO's overall financial quality at 31 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy SILO?

Deepscope's AI Timing Score for SILO is 96 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does SILO belong to?

SILO PHARMA INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Stock Check   *Daily update data at 9:30 AM*
(Price: 2026-06-03 | FS: 2026-03-31)

SILO

SILO PHARMA INC
USD 6.13
5.78 (1,650.93%) Day Change
0.24
D/E
-85.2%
ROE
-69.0%
ROA
0.00%
Div Yield
USD 6.13
Price
5.78 (1,650.93%)
Day Change
NEWS SCORE: 91

SILO, the overall quality is not good ( Quality = 31) but the timing to buy is ...(Sign In to See)...

31

QUALITY

Signal
UNDERPERFORM
Signal Description
Company financial health is Not Good
Reason
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.

88 Sign in

TIMING

Signal
OUTPERFORM
Signal Descri...
Good
Reason
Lorem ipsum dolor sit amet
Sign in to see timing analysis
Unlock timing signals and detailed reasons
Sign in free

In details, quality factors are not good , financial health is not quite good , and ability to make profit is not quite good , ...

Quality Factors 48%
X
X
X
X
  In Recommendations? Not in any sections
  Select Rate 0.00 From 30 days period
  Watch Rate 0.00 From 30 days period
  News Score 91
  Magic Formula Rank by ROA
N/A
  Magic Formula Rank by ROE
N/A
  Magic Formula Rank by ROIC
N/A
  Price 6.13
  PBV / Sector
0.07 / 4.48
GREAT
  Earning Per Share -78.20
  PE / Sector
N/A / 16.68
  PEG or PE/Growth / Sector
N/A / 0.53
  Average 1M Daily Value
0.44 M
GREAT
  Average 1W Daily Value
0.44 M
GREAT
Timing Factors 71%
  MACD
  MACD Signal
  MACD Divergence
  RSI
  Stochastic Oscillator K
  Stochastic Oscillator D
  ADX
  Avg 5 day Timing Score
Financial Health 50%
X
X
X
X
  DE / Sector
  DE Average / Sector
  DE Change Average (%) / Sector
  Current Ratio / Sector
  Current Ratio Average / Sector
  Current Ratio Change Average (%) / Sector
  Quick Ratio / Sector
  Quick Ratio Average / Sector
  Quick Ratio Change Average (%) / Sector
  FCF/Share / Sector
  FCF/Share Average / Sector
  FCF/Share Change Average (%) / Sector
Ability to Make Profit 52%
X
X
X
X
X
X
X
  GPM (%) / Sector
  GPM Average (%) / Sector
  GPM Change Average (%) / Sector
  OPM (%) / Sector
  OPM Average (%) / Sector
  OPM Change Average (%) / Sector
  NPM (%) / Sector
-6,717.40 / 450.37
  NPM Average (%) / Sector
-5,845.38 / -1,506.30
  NPM Change Average (%) / Sector
6.05 / 4,941.44
  Asset Turnover / Sector
  Asset Turnover Average / Sector
  Asset Turnover Change Average (%) / Sector
  ROA (%) / Sector
-69.01 / 30.83
  ROA Average (%) / Sector
-53.04 / -347.12
  ROA Change Average (%) / Sector
21.08 / 5,126.35
GREAT
  ROE (%) / Sector
-85.24 / -3.04
  ROE Average (%) / Sector
-67.45 / 40.76
  ROE Change Average (%) / Sector
27.03 / 2,110.63
GREAT
  ROIC (%) / Sector
  ROIC Average (%) / Sector
  ROIC Change Average (%) / Sector
Return to Investors 8%
X
  Dividend (%) / Sector
N/A / 0.05
  Dividend Average (%) / Sector
N/A / 16.49
  Dividend Change Average (%) / Sector
N/A / 5.25
Registration Details
X
  Analyze Date 2026-06-04 09:24:07
  Symbol SILO
  Name SILO PHARMA INC
  Sector Healthcare >> Biotechnology
  Market NASDAQ
  Listed Shares 1.08 M
  Par Value N/A
  Calculated From Quarter
  Sign N/A
  Market Cap (M.USD) / Sector Average 0.38 / 8,483.11
News, Concensus, ...
  Estimation Consensus See at WSJ.com
  Full details See at WSJ.com
  Chart See in Chart feature
  News See at Yahoo Finance

Address: 677 North Washington Boulevard, Sarasota, FL, United States, 34236

Phone: 718 400 9031

Website: https://silopharma.com

Sector: Healthcare >> Biotechnology

Description: Silo Pharma Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida.

ME vs SECTOR Healthcare >> Biotechnology

SILO (ME)
Sector Peers
Bubble size = Market Cap

Click a bubble to view stock details  ·  Bubble size represents market capitalization share

News

Smart picks. Just WOW stocks/funds/ETFs. No noise like other tools.
SILO
SILO
USD 6.13 (1,650.93%)
+ Watch + Port Chart